Adipose Stromal Cells Amplify Angiogenic Signaling via the VEGF/mTOR/Akt Pathway in a Murine Hindlimb Ischemia Model: A 3D Multimodality Imaging Study

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Fan, Weiwei ^a   Sun, Dongdong ^a   Liu, Junting ^b   Liang, Dong ^a   Wang, Yabin ^a   Narsinh, Kazim H ^c   Li, Yong ^a   Qin, Xing ^a   Liang, Jimin ^b   Tian, Jie ^b   Cao, Feng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b XIDIAN UNIVERSITY   (China)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; LUCIFERASE; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; BIOLUMINESCENCE; BIOLUMINESCENCE TOMOGRAPHY; CELL SURVIVAL; CELL TRANSPORT; CELLULAR DISTRIBUTION; COLLATERAL CIRCULATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DOWN REGULATION; EXCISION; EXPERIMENTAL MOUSE; FEMORAL ARTERY; FLUORESCENCE IMAGING; HINDLIMB; IMMUNOFLUORESCENCE; IN VIVO STUDY; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; MICRO-COMPUTED TOMOGRAPHY; MOLECULAR IMAGING; MOTOR PERFORMANCE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; QUANTITATIVE STUDY; REPORTER GENE; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; THREE DIMENSIONAL IMAGING; TISSUE PERFUSION; TOMOGRAPHY;

ADIPOSE TISSUE; ANIMALS; CELL TRANSPLANTATION; HINDLIMB; IMAGING, THREE-DIMENSIONAL; ISCHEMIA; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STROMAL CELLS; TOR SERINE-THREONINE KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE; MUS;

EID: 84866697009     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045621     Document Type: Article

References (37)

1. ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 124: 2020-2045.
2. Hiatt WR, (2001) Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344: 1608-1621.
3. Lawall H, Bramlage P, Amann B, (2011) Treatment of peripheral arterial disease using stem and progenitor cell therapy. J Vasc Surg 53: 445-453.
4. Aranguren XL, Verfaillie CM, Luttun A, (2009) Emerging hurdles in stem cell therapy for peripheral vascular disease. J Mol Med (Berl) 87: 3-16.
5. Mizuno H, Tobita M, Uysal AC, (2012) Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 30: 804-810.
6. Gimble JM, Bunnell BA, Guilak F, (2012) Human adipose-derived cells: an update on the transition to clinical translation. Regen Med 7: 225-235.
7. Hong SJ, Traktuev DO, March KL, (2010) Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Curr Opin Organ Transplant 15: 86-91.
8. Cao F, Wagner RA, Wilson KD, Xie X, Fu JD, et al. (2008) Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS One 3: e3474.
9. Chen IY, Wu JC, (2011) Cardiovascular molecular imaging: focus on clinical translation. Circulation 123: 425-443.
10. Cao F, Lin S, Xie X, Ray P, Patel M, et al. (2006) In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113: 1005-1014.
11. Cao F, Li Z, Lee A, Liu Z, Chen K, et al. (2009) Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation. Cancer Res 69: 2709-2713.
12. Liu J, Wang Y, Qu X, Li X, Ma X, et al. (2010) In vivo quantitative bioluminescence tomography using heterogeneous and homogeneous mouse models. Opt Express 18: 13102-13113.
13. Liu J, Chen D, Li X, Ma X, Chen H, et al. (2010) In vivo quantitative reconstruction studies of bioluminescence tomography: effects of peak-wavelength shift and model deviation. IEEE Trans Biomed Eng 57: 2579-2582.
14. Tirziu D, Moodie KL, Zhuang ZW, Singer K, Helisch A, et al. (2005) Delayed arteriogenesis in hypercholesterolemic mice. Circulation 112: 2501-2509.
15. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.
16. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K, (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301.
17. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, et al. (1997) Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26: 517-538.
18. Xie X, Cao F, Sheikh AY, Li Z, Connolly AJ, et al. (2007) Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function. Cloning Stem Cells 9: 549-563.
19. Sun D, Huang J, Zhang Z, Gao H, Li J, et al. (2012) Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS One 7: e33491.
20. Salgado AJ, Reis RL, Sousa NJ, Gimble JM, (2010) Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 5: 103-110.
21. Holmes K, Roberts OL, Thomas AM, Cross MJ, (2007) Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 19: 2003-2012.
22. Falcon BL, Barr S, Gokhale PC, Chou J, Fogarty J, et al. (2011) Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors. Cancer Res 71: 1573-1583.
23. Kitamura T, Asai N, Enomoto A, Maeda K, Kato T, et al. (2008) Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol 10: 329-337.
24. van der Bogt KE, Hellingman AA, Lijkwan MA, Bos EJ, de Vries MR, et al. (2012) Molecular imaging of bone marrow mononuclear cell survival and homing in murine peripheral artery disease. JACC Cardiovasc Imaging 5: 46-55.
25. Sheikh AY, Huber BC, Narsinh KH, Spin JM, van der Bogt K, et al. (2012) In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium. Arterioscler Thromb Vasc Biol 32: 92-102.
26. Edinger M, Cao YA, Verneris MR, Bachmann MH, Contag CH, et al. (2003) Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101: 640-648.
27. Matzke M, Matzke AJ, Kooter JM, (2001) RNA: guiding gene silencing. Science 293: 1080-1083.
28. Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, et al. (2004) Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110: 349-355.
29. Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, et al. (2004) Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109: 656-663.
30. Traktuev DO, Prater DN, Merfeld-Clauss S, Sanjeevaiah AR, Saadatzadeh MR, et al. (2009) Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circ Res 104: 1410-1420.
31. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, et al. (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109: 1292-1298.
32. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, et al. (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124: 175-189.
33. Robey TE, Saiget MK, Reinecke H, Murry CE, (2008) Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45: 567-581.
34. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L, (2006) VEGF receptor signalling- in control of vascular function. Nat Rev Mol Cell Biol 7: 359-371.
35. Lakshmikanthan S, Sobczak M, Chun C, Henschel A, Dargatz J, et al. (2011) Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin alphavbeta. Blood 118: 2015-2026.
36. Humar R, Kiefer FN, Berns H, Resink TJ, Battegay EJ, (2002) Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J 16: 771-780.
37. Trinh XB, Tjalma WA, Vermeulen PB, Van den Eynden G, Van der Auwera I, et al. (2009) The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. Br J Cancer 100: 971-978.